Finance

Lists
Why is CCEL up 4,56%?
Dive Deeper
CCEL:NYSEAMERICAN
Cryo-Cell International Inc
4,36 $
+4,56%
(+0,19) 1D
9 հոկ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CCEL...
Open
4,00 $
High
4,47 $
Low
4,00 $
Mkt. cap
35,15 մլն
Avg. vol.
13,42 հզր
Volume
5,47 հզր
52-wk high
4,90 $
52-wk low
2,72 $
EPS
-0,31 $
Beta
0,08
Shares outstanding
8,06 մլն
No. of employees
74
Open
4,00 $
High
4,47 $
Low
4,00 $
Mkt. cap
35,15 մլն
Avg. vol.
13,42 հզր
Volume
5,47 հզր
52-wk high
4,90 $
52-wk low
2,72 $
EPS
-0,31 $
Beta
0,08
Shares outstanding
8,06 մլն
No. of employees
74
News stories
From web sources and news partners
Profile
Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL. Wikipedia
About Cryo-Cell International Inc
CEOMark L. Portnoy | David I. Portnoy
Employees74
Founded1989
HeadquartersOldsmar, Ֆլորիդա, Միացյալ Նահանգներ
SectorHealth care provider
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. օգս
2025 թ. նոյ
2026 թ. փտվ
2026 թ. մյս
Revenue
7,83 մլն
7,84 մլն
7,68 մլն
7,78 մլն
Cost of goods sold
1,80 մլն
6,09 մլն
1,66 մլն
1,68 մլն
Cost of revenue
1,80 մլն
6,09 մլն
1,66 մլն
1,68 մլն
Research and development expenses
61,62 հզր
84,78 հզր
65,76 հզր
99,78 հզր
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,88 մլն
5,45 մլն
5,01 մլն
4,62 մլն
Operating expense
4,12 մլն
5,72 մլն
5,26 մլն
4,90 մլն
Total operating expenses
5,92 մլն
11,81 մլն
6,92 մլն
6,58 մլն
Operating income
1,90 մլն
-3,97 մլն
765,13 հզր
1,20 մլն
Other non operating income
17,56 հզր
18,41 հզր
8,34 հզր
338,00
EBT including unusual items
1,19 մլն
-4,63 մլն
70,31 հզր
827,78 հզր
EBT excluding unusual items
1,38 մլն
-4,43 մլն
310,77 հզր
755,76 հզր
Income tax expense
436,59 հզր
-814,54 հզր
23,20 հզր
273,20 հզր
Effective tax rate
36,81%
17,59%
33,00%
33,00%
Other operating expenses
-
-
-
-
Net income
749,41 հզր
-3,82 մլն
47,11 հզր
554,59 հզր
Net profit margin
9,58%
-48,67%
0,61%
7,13%
Earnings per share
0,10
-0,47
0,02
0,07
Interest and investment income
-
-
-
-
Interest expense
-538,22 հզր
-481,95 հզր
-462,71 հզր
-441,92 հզր
Net interest expenses
-538,22 հզր
-481,95 հզր
-462,71 հզր
-441,92 հզր
Depreciation and amortization charges
185,69 հզր
183,83 հզր
183,89 հզր
184,33 հզր
EBITDA
2,14 մլն
-3,72 մլն
1,01 մլն
1,44 մլն
Gain or loss from assets sale
633,00
-
-
-
AI content may include mistakes. Learn more
Google Apps